New legislation introduced in the US House of Representatives just prior to the holiday break would amend the Federal Food, Drug and Cosmetic Act (FD&C Act) to increase penalties on the sale or trade of counterfeit pharmaceuticals and also grant the US Food and Drug Administration (FDA) new authority to recall drugs.
- See more at: http://www.raps.org/focus-online/news.aspx#sthash.gRC0XjKm.dpuf
No comments:
Post a Comment